Healthcare private equity firms invest in operating businesses such as provider groups, outsourced services, healthcare software, products and distribution. The useful shortlist starts with your business model, maturity and ownership goals, not the word “healthcare” in a firm's name. A growth or buyout partner for an established revenue-cycle business is a different prospect from a venture investor funding a drug candidate.
This guide compares six firms using their published strategies, then shows how to turn that research into a practical fit worksheet. It is written for business owners and management teams researching capital partners, not for patients or people choosing an investment fund.
Define the business and transaction before choosing firms
Write a one-paragraph brief covering what the company does, who pays it, where it operates, how mature its operations are and what the owners want to change. “Healthcare platform raising capital” leaves too much unanswered. “An established US outsourced billing business seeking an ownership partner and acquisition support” gives a researcher a useful starting point.
| Question | Useful distinction | Evidence to prepare |
|---|---|---|
| What is being financed? | A care provider, services vendor, software company, product manufacturer or distributor | Revenue by offering, customer type and geography |
| How mature is the business? | An operating company versus a research program or precommercial startup | Historical financials, customer concentration and operating history |
| What is the transaction? | Growth capital, shareholder liquidity, a buyout, recapitalization or acquisition funding | A clear separation of company proceeds and selling-shareholder proceeds |
| What role do owners want afterward? | Continuing leadership, a transition or a different ownership arrangement | Founder goals, management responsibilities and open governance questions |
| What requires specialist review? | Clinical authority, professional ownership, reimbursement, privacy or compliance questions | A question register for appropriate counsel, accountants and healthcare specialists |
If the business is an early-stage technology company, begin with our healthtech investor guide. A research-led life sciences company belongs in the separate biotech and life sciences investor landscape. Those are adjacent capital markets, not interchangeable lists.
Six healthcare private equity firms to research
The table is a research map, not a ranking. Inclusion means the firm publishes a relevant strategy. It does not mean it is accepting your transaction, has approved your business or offers a particular ownership structure. Do not treat a firm's total assets or fund size as the check available to you.
| Firm | Published focus | Question that changes the shortlist |
|---|---|---|
| Frazier Healthcare Partners | Thematic healthcare investing with an executive-in-residence model and growth-buyout work | Does the business fit a current operating theme and the leadership plan? |
| Waud Capital Partners | North American middle-market healthcare and software/technology businesses | Which sector team and transaction model match this company? |
| Revelstoke Capital Partners | Healthcare services, healthcare technology, health and wellness businesses | Is the company a platform opportunity or a fit with an existing business? |
| Shore Capital Partners | Healthcare-focused funds with distinct platform and add-on criteria | Which fund and platform/add-on route actually applies? |
| Linden Capital Partners | Healthcare services, products and distribution subsectors | Which current industry focus matches the revenue model? |
| Varsity Healthcare Partners | Lower-middle-market provider platforms and businesses serving providers or payers | Do the transaction goals fit its primarily control-oriented approach? |
Frazier Healthcare Partners: operating themes and leadership fit
Frazier's approach connects long-term healthcare themes, experienced executives, platform selection and business transformation. Its executive-in-residence model makes the management plan an important part of research. Ask how the existing team would work with any additional leadership and what operating problem the proposed partnership is meant to solve.
Use the firm's official contact page for an initial routing inquiry. Its current notice says Frazier Healthcare and Frazier Life Sciences are separate, independent firms with no current affiliation. Do not merge their mandates or contacts into one investor record.
Waud Capital Partners: sector and executive alignment
Waud describes a North American middle-market focus spanning healthcare and software/technology, with dedicated research, human-capital, investment, operations and business-development functions. A healthcare IT company should identify the correct investment team rather than assume that every healthcare contact owns software transactions.
Prepare the operating history, leadership needs and proposed growth work before asking about fit. Review the current approach and team navigation on its official site; do not use an investor-login link as a company-submission route. Ownership expectations need direct confirmation for the proposed transaction.
Revelstoke Capital Partners: services and technology
Revelstoke identifies healthcare services, healthcare technology, and health and wellness as its investment areas and describes working with entrepreneurs and managers. The distinction to resolve is whether the business is being considered as a new platform or in relation to an existing portfolio company.
Its contact page separates investment opportunities from investor relations. Use the relevant route for a concise, nonconfidential introduction. Ask which operating capabilities and transaction scale the team is currently seeking; a similar portfolio company alone does not establish fit.
Shore Capital Partners: platform versus add-on
Shore's healthcare page identifies specific niches, including lab services, revenue-cycle management, medical-device outsourcing, healthcare supply-chain services and provider-related services. It separately presents its Healthcare Advantage Fund and Shore Capital Healthcare Partners, with different platform parameters and add-on criteria.
That separation matters. A company outside a platform range may require a different conversation, but an add-on row is not a promise that a portfolio company wants to acquire it. Use Shore's founder/operator contact form to confirm the relevant fund, team and role before sharing detailed materials.
Linden Capital Partners: identify the exact healthcare subsector
Linden's industry map distinguishes services, products and distribution. Its examples include healthcare IT, payer services, multi-site providers, contract manufacturing and specialty distribution. That makes the commercial model a better filter than a broad “healthcare innovation” label.
For a manufacturer, discuss production and customer concentration. For a services business, explain the buyer, recurring work and delivery model. These are different diligence stories. The official site publishes a general inquiry route; confirm the appropriate investment professional and current transaction mandate rather than inferring an open process from the portfolio.
Varsity Healthcare Partners: provider platforms and supporting businesses
Varsity's overview focuses on multi-site healthcare provider platforms and outsourced services, technology or tools used by providers and payers. It describes growth equity through buyout/recapitalization, primarily control investments with some exceptions, and founder/shareholder rollover.
An owner seeking only a small passive investment should resolve that structural question early. A management team considering a broader partnership should prepare its leadership and operating plan. Varsity publishes a general contact route; that route is not transaction approval or permission to send patient-level information.
Worked example: an outsourced healthcare-services company
The following company and figures are entirely fictional. Cedar Revenue Services provides billing support to outpatient groups in three US states. It has $18 million of annual revenue, a continuing founder-led team and a plan to acquire a complementary service business. The founder wants some liquidity but has not decided whether to accept a control transaction.
The first task is not to score all six firms from one to ten. It is to resolve the facts that would make a conversation useful.
| Research branch | Evidence-based starting point | Unresolved decision |
|---|---|---|
| Subsector | Shore explicitly lists revenue-cycle management; Linden lists healthcare services and healthcare IT | Does Cedar's labor-and-service revenue model fit a current theme? |
| Transaction role | Shore distinguishes platforms and add-ons; Varsity describes primarily control investments | Is Cedar seeking a standalone partner, a combination with a platform or something else? |
| Management | Frazier and Waud emphasize experienced executives and business building | Which responsibilities would the founder retain, and what leadership support is needed? |
| Information readiness | Cedar has financial statements but no agreed sharing plan | Who will approve redaction, confidentiality and the initial document set? |
The result is a short research queue and a founder decision, not an investment recommendation. Cedar first clarifies its control preference, separates acquisition capital from shareholder liquidity and prepares a nonconfidential overview. It then asks the relevant teams about current mandate and process. None of the firms is portrayed as interested in this fictional company.
Copy the healthcare capital-partner worksheet
Business profile
Company: [Company name]
Internal owner: [Name and role]
Review date: [YYYY-MM-DD]
Business model: [Provider / outsourced service / software / product / distribution]
Customers and payers: [Who buys, who uses and who pays]
Operating geographies and entity structure: [Locations and relevant entities]
Revenue model and business maturity: [Description supported by current evidence]
Financial source documents: [Document names, dates and locations]
Capital purpose: [Company growth / acquisition / shareholder liquidity / other]
Founder goals and post-transaction responsibilities: [Desired outcome and continuing role]
Control preference: [Agreed / open / unresolved; explain the preference]
Firm comparison
Repeat this record for each distinct firm.
Firm and exact team or fund: [Current names]
Official mandate URL and date checked: [URL; YYYY-MM-DD]
Subsector and business-model match: [Evidence and its limits]
Geography, maturity and transaction role: [Documented fit or unanswered questions]
Platform or add-on route: [Relevant route / not applicable / unknown]
Ownership and management questions: [Specific issues to discuss]
Current portfolio overlap: [Relevant overlap and why it matters]
Public inquiry route and submission restrictions: [Official route; any stated limits]
Evidence state: [Confirmed / interpretation / unknown]
Research decision: [Research further / pause / exclude]
Reason for the decision: [Supporting evidence, not an assumed approval]
Specialist question register
Cover clinical authority or professional ownership; reimbursement and commercial contracts; privacy, security and permitted sharing; and accounting, tax and transaction structure.
Repeat this record for each question.
Issue or question: [One specific unresolved item]
Appropriate professional: [Name and role]
Evidence needed: [Documents, source references or clarification]
Internal owner: [Person coordinating the answer]
Status: [Current review status and unresolved points]
Next action
One nonconfidential question: [Question for the relevant team]
Permission needed before sharing documents: [Required permission and responsible person]
Internal owner: [Name]
Next review trigger: [Response, evidence update or review date]
Response receipt: [Actual response and date, or not yet received]Prepare an initial conversation without oversharing
Share the business model, operating geography, broad company scale, management goals and transaction purpose first. Ask whether the team covers that type of opportunity and what it needs to assess fit. Do not send patient records, employee personal data, privileged advice or restricted customer information because a website has a contact form.
For later diligence, create a controlled financial and operating evidence set. If the capital need is principally borrowing rather than an ownership transaction, compare the separate private-credit lender landscape. Keep lender and equity-partner records distinct, even when one organization offers both.
Sources and editorial method
Prepared by Finta Editorial Team. Official strategy and contact pages checked October 20, 2026. These six firms were selected for a published healthcare operating-business mandate and useful differences in approach, not ranked by returns or likelihood of financing. Provider descriptions are self-reported. The screening framework, worksheet and Cedar case are original educational materials. Current capacity, exact eligibility, commercial terms and willingness to engage require direct confirmation.
Informational purposes only. This is general business education, not personalized investment, financial, legal, tax or medical advice. Finta is not a law or accounting firm. Consult your attorney, accountant and appropriate healthcare professionals about your circumstances, ownership structure, compliance and transaction documents.